← All indications
Surgical Wound Infection
Infection occurring at the site of a surgical incision.
Drugs by status
Phase 4 trials (33)
- metronidazole
- ceftaroline fosamil
- procaine benzylpenicillin
- betaine
- tobramycin
- bifidobacterium animalis
- cefazolin
- clavulanate
- iodine
- amoxicillin
- hyaluronidase (human recombinant)
- mupirocin
- ceftriaxone
- sulbactam
- vancomycin
- ciprofloxacin
- oligofructose
- isopropyl alcohol
- iodine povacrylex
- oxygen
- cefuroxime
- cephalexin
- polyglactin 910
- sodium chloride
- ertapenem
- chlorhexidine
- triclosan
- bacitracin
- neomycin
- erythromycin
- +3 more
Phase 3 trials (19)
Phase 2 trials (6)
Phase 1 trials (3)
Organizations
Organization Involved with Phase 4 Indications (60)
- 3M
- Forest Laboratories
- Cubist
- GlaxoSmithKline
- Lindenhof AG
- Mepha Ltd.
- ZonMw: The Netherlands Organisation for Health Research and Development
- Cairo University
- Changhua Christian Hospital
- Harvard University
- Geisinger Clinic
- Hospital de Granollers
- KAT General Hospital
- McMaster University
- Minia University
- New York University
- Sanford Health
- Universitat Internacional de Catalunya
- University of Hull
- University of Iowa
- University of Lausanne
- University of Southern Denmark
- University of Tennessee
- University of Athens
- University of Bern
- Tel Aviv University
- University of California, San Francisco
- University of Cincinnati
- University of Colorado, Denver
- University of Copenhagen
- +30 more
Organization Involved with Phase 3 Indications (63)
- Durata
- Merck
- Allergan
- Innocoll
- Menarini Group
- PolyPid Ltd.
- Zurex Pharma, Inc.
- National Cancer Center, Korea
- National Institute of Allergy and Infectious Diseases (NIAID)
- National Institute of General Medical Sciences (NIGMS)
- Silvia M. Pinango L.
- Baylor University
- University of London
- Dow University of Health Sciences
- Duke University
- Horizon Health Network
- King Edward Medical University
- Johns Hopkins University
- Major Extremity Trauma Research Consortium
- Los Angeles Biomedical Research Institute
- Medical College of Wisconsin
- Onze Lieve Vrouw Hospital
- Universidad Autonoma de Madrid
- Cayetano Heredia University
- University of Edinburgh
- University of Louisville
- University of Maryland
- University of Rochester
- University of Birmingham
- University of the Philippines
- +33 more
Organization Involved with Phase 2 Indications (22)
- Destiny Pharma Ltd
- Pulmatrix Inc.
- Attabib, Najmedden, M.D.
- University of Arizona
- Ain Shams University
- Seoul National University
- Universidad Tecnológica de Pereira
- Universidade do Vale do Sapucai
- University of Leeds
- University of South Alabama
- University of Southern California
- University of California, San Diego
- University of Freiburg
- Shoals Medical Trials
- BJJS Corporation
- Saint John Regional Hospital
- Daehang Hospital
- Dr. Reddy's Laboratories
- University of Sao Paulo
- Bio-Science Laboratories
- Stryker
- Universidad San Jorge
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (53)
- Novo Nordisk
- National Institutes of Health (NIH)
- Shahid Beheshti University of Medical Sciences
- The Methodist Hospital System
- Case Western Reserve University
- Hillel Yaffe Medical Center
- Hospital Universitario Central de Asturias
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- Lakehead University
- Northwestern University
- Ochsner Health System
- Oregon Health and Science University
- Saint Thomas Hospital, Panama
- Universidad Complutense de Madrid
- University of Oslo
- University of South Florida
- University of Valencia
- Genesys
- Genesys Regional Medical Center
- University of Utah
- Wright State University
- University of Basel
- Queen Elizabeth Hospital, Kota Kinabalu, Sabah, Malaysia
- University of Rwanda
- Hospital Son Espases, Palma Mallorca
- Orebro University
- The University of Hong Kong
- Sun Yat-Sen University
- Mario Negri Institute
- Hospital general Universitario de Ciudad Real
- +23 more